What top creators are saying about BridgeBio Pharma, Inc.(BBIO)
Biopharmaceutical company developing medicines for genetic diseases
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 2 scored insights about BridgeBio Pharma, Inc..
Top creators covering BridgeBio Pharma, Inc. (BBIO)
The 2 sources with the most insights about BridgeBio Pharma, Inc. on Kazuha.
Latest insights about BridgeBio Pharma, Inc. (BBIO)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
Mentioned while checking upcoming earnings dates; no company-specific thesis or position was discussed.
Tuesday, October 6, 2026
Mentioned near discussion of earnings-date announcements, without a specific date or investment thesis.
Yesterday
Mentioned while checking upcoming earnings dates; no company-specific thesis or position was discussed.
Tuesday, October 6, 2026
Mentioned near discussion of earnings-date announcements, without a specific date or investment thesis.
Discussed alongside BridgeBio Pharma, Inc. (BBIO)
Other assets that creators frequently mention in the same content as BridgeBio Pharma, Inc..
Frequently asked
Which podcasters and creators cover BridgeBio Pharma, Inc. (BBIO) the most?
The most active sources covering BridgeBio Pharma, Inc. (BBIO) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about BridgeBio Pharma, Inc. (BBIO) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about BridgeBio Pharma, Inc. (BBIO) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside BridgeBio Pharma, Inc. (BBIO)?
Creators covering BridgeBio Pharma, Inc. (BBIO) most frequently also discuss 000660.KS, ASML, DNA, INTC, AAOI. See the "Discussed alongside" section above for full asset pages.